447 related articles for article (PubMed ID: 17222176)
21. Investigations of the molecular mechanism of metal-induced Abeta (1-40) amyloidogenesis.
Lim KH; Kim YK; Chang YT
Biochemistry; 2007 Nov; 46(47):13523-32. PubMed ID: 17973493
[TBL] [Abstract][Full Text] [Related]
22. Copper and zinc binding properties of the N-terminal histidine-rich sequence of Haemophilus ducreyi Cu,Zn superoxide dismutase.
Paksi Z; Jancsó A; Pacello F; Nagy N; Battistoni A; Gajda T
J Inorg Biochem; 2008 Sep; 102(9):1700-10. PubMed ID: 18565588
[TBL] [Abstract][Full Text] [Related]
23. Influence of multiple metal ions on beta-amyloid aggregation and dissociation on a solid surface.
Ryu J; Girigoswami K; Ha C; Ku SH; Park CB
Biochemistry; 2008 May; 47(19):5328-35. PubMed ID: 18422346
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the high affinity heparin binding site of the Alzheimer's disease beta A4 amyloid precursor protein (APP) and its enhancement by zinc(II).
Multhaup G; Mechler H; Masters CL
J Mol Recognit; 1995; 8(4):247-57. PubMed ID: 8588942
[TBL] [Abstract][Full Text] [Related]
25. Metal loading capacity of Abeta N-terminus: a combined potentiometric and spectroscopic study of zinc(II) complexes with Abeta(1-16), its short or mutated peptide fragments and its polyethylene glycol-ylated analogue.
Damante CA; Osz K; Nagy Z; Pappalardo G; Grasso G; Impellizzeri G; Rizzarelli E; Sóvágó I
Inorg Chem; 2009 Nov; 48(21):10405-15. PubMed ID: 19780525
[TBL] [Abstract][Full Text] [Related]
26. The second Cu(II)-binding site in a proton-rich environment interferes with the aggregation of amyloid-beta(1-40) into amyloid fibrils.
Jun S; Gillespie JR; Shin BK; Saxena S
Biochemistry; 2009 Nov; 48(45):10724-32. PubMed ID: 19824649
[TBL] [Abstract][Full Text] [Related]
27. Characterizing bathocuproine self-association and subsequent binding to Alzheimer's disease amyloid beta-peptide by NMR.
Yao S; Cherny RA; Bush AI; Masters CL; Barnham KJ
J Pept Sci; 2004 Apr; 10(4):210-7. PubMed ID: 15119593
[TBL] [Abstract][Full Text] [Related]
28. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease.
Rodríguez-Rodríguez C; Sánchez de Groot N; Rimola A; Alvarez-Larena A; Lloveras V; Vidal-Gancedo J; Ventura S; Vendrell J; Sodupe M; González-Duarte P
J Am Chem Soc; 2009 Feb; 131(4):1436-51. PubMed ID: 19133767
[TBL] [Abstract][Full Text] [Related]
29. Effects of zinc binding on the conformational distribution of the amyloid-beta peptide based on molecular dynamics simulations.
Li W; Zhang J; Su Y; Wang J; Qin M; Wang W
J Phys Chem B; 2007 Dec; 111(49):13814-21. PubMed ID: 18001084
[TBL] [Abstract][Full Text] [Related]
30. Modeling of the Zn2+ binding in the 1-16 region of the amyloid beta peptide involved in Alzheimer's disease.
Furlan S; La Penna G
Phys Chem Chem Phys; 2009 Aug; 11(30):6468-81. PubMed ID: 19809679
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effect of copper(II) on zinc(II)-induced aggregation of amyloid beta-peptide.
Suzuki K; Miura T; Takeuchi H
Biochem Biophys Res Commun; 2001 Jul; 285(4):991-6. PubMed ID: 11467850
[TBL] [Abstract][Full Text] [Related]
32. Structural studies of soluble oligomers of the Alzheimer beta-amyloid peptide.
Huang TH; Yang DS; Plaskos NP; Go S; Yip CM; Fraser PE; Chakrabartty A
J Mol Biol; 2000 Mar; 297(1):73-87. PubMed ID: 10704308
[TBL] [Abstract][Full Text] [Related]
33. Solution NMR studies of the A beta(1-40) and A beta(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation.
Hou L; Shao H; Zhang Y; Li H; Menon NK; Neuhaus EB; Brewer JM; Byeon IJ; Ray DG; Vitek MP; Iwashita T; Makula RA; Przybyla AB; Zagorski MG
J Am Chem Soc; 2004 Feb; 126(7):1992-2005. PubMed ID: 14971932
[TBL] [Abstract][Full Text] [Related]
34. Liquid chromatography/tandem mass spectrometry characterization of oxidized amyloid beta peptides as potential biomarkers of Alzheimer's disease.
Inoue K; Garner C; Ackermann BL; Oe T; Blair IA
Rapid Commun Mass Spectrom; 2006; 20(5):911-8. PubMed ID: 16470704
[TBL] [Abstract][Full Text] [Related]
35. pH-dependence of the specific binding of Cu(II) and Zn(II) ions to the amyloid-β peptide.
Ghalebani L; Wahlström A; Danielsson J; Wärmländer SK; Gräslund A
Biochem Biophys Res Commun; 2012 May; 421(3):554-60. PubMed ID: 22525674
[TBL] [Abstract][Full Text] [Related]
36. Metal-binding properties of the peptide APP170-188: a model of the ZnII-binding site of amyloid precursor protein (APP).
Ciuculescu ED; Mekmouche Y; Faller P
Chemistry; 2005 Jan; 11(3):903-9. PubMed ID: 15593132
[TBL] [Abstract][Full Text] [Related]
37. Role of aspartate-1 in Cu(II) binding to the amyloid-beta peptide of Alzheimer's disease.
Karr JW; Szalai VA
J Am Chem Soc; 2007 Apr; 129(13):3796-7. PubMed ID: 17352478
[No Abstract] [Full Text] [Related]
38. Controlling amyloid growth in multiple dimensions.
Dong J; Lu K; Lakdawala A; Mehta AK; Lynn DG
Amyloid; 2006 Dec; 13(4):206-15. PubMed ID: 17107881
[TBL] [Abstract][Full Text] [Related]
39. Zinc-induced dimerization of the amyloid-β metal-binding domain 1-16 is mediated by residues 11-14.
Kozin SA; Mezentsev YV; Kulikova AA; Indeykina MI; Golovin AV; Ivanov AS; Tsvetkov PO; Makarov AA
Mol Biosyst; 2011 Apr; 7(4):1053-5. PubMed ID: 21350790
[TBL] [Abstract][Full Text] [Related]
40. Engineered non-fluorescent Affibody molecules facilitate studies of the amyloid-beta (Aβ) peptide in monomeric form: low pH was found to reduce Aβ/Cu(II) binding affinity.
Lindgren J; Segerfeldt P; Sholts SB; Gräslund A; Karlström AE; Wärmländer SK
J Inorg Biochem; 2013 Mar; 120():18-23. PubMed ID: 23262458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
